Family Medicine
Partner With Us
Advertisement
Conexiant chevron_right Family Medicine chevron_right Latest Headlines

Latest Headlines

thumb description

June 09, 2026

FDA Permits New Sunscreen Ingredient After 20 Years

The sunscreen ingredient, which has been marketed internationally for years, is considered generally recognized as safe and effective for use in adults and pediatric patients aged 6 months and older.

Conexiant

thumb description

June 09, 2026

Salivary Marker May Reveal Sleep Deprivation

A machine-learning model distinguished samples collected following 1 night of total sleep deprivation from control and sleep-restriction conditions in a randomized crossover study of healthy young men.

Conexiant

thumb description

June 09, 2026

Less Sitting in Pregnancy Tied to Lower Risk

Pregnant patients who sat less and moved more at light intensity had a lower risk of adverse outcomes in a prospective cohort study, but the findings do not prove causation.

Conexiant

thumb description

June 09, 2026

Side Effects: Context Is the Diagnosis

This week's research makes one thing clear: who someone is before they get sick — their relationships, their partner's health, the back of their eye — is doing a lot of work medicine is only beginning to account for.

Conexiant

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

thumb description

June 09, 2026

Tranexamic Acid Reduces Previa Bleeding

The composite endpoint reached statistical significance, but transfusion alone did not, and the single-country design may limit applicability across populations.

Conexiant

thumb description

June 09, 2026

Semaglutide Tied to Aging Clocks in HIV

A posthoc analysis of a phase 2b trial found favorable changes in DNA methylation–based aging biomarkers among patients with human immunodeficiency virus–associated lipohypertrophy.

Conexiant

thumb description

June 09, 2026

SGLT2 Inhibitors Tied to Lower Kidney Cancer Risk

A Korean cohort study found fewer kidney cancer cases among patients with type 2 diabetes who initiated sodium-glucose cotransporter 2 inhibitors vs dipeptidyl peptidase-4 inhibitors.

Conexiant